ÂÜÀòÂÒÂ×

Martin Welschof is the current Chief Executive Officer at BioInvent International. Prior to this, they held various management positions at different companies. These include CEO of Opsona Therapeutics Ltd, Non Executive Director of ExpreS2ion Biotechnologies, and Managing Director of Affitech A/S. Martin has also been involved with Axaron Bioscience AG as Director of Technology.

Martin Welschof received their PhD in Biology from Bielefeld University and is currently a postdoctoral fellow in recombinant antibody technologies at Heidelberg University. Prior to their current position, they worked in the field of agriculture at The University of Bonn.

Some direct reports include Marie Moores - Chief Operating Officer, Andres Mcallister - Chief Medical Officer, and Sylvie Ryckebusch - Chief Business Officer.